Biocon Ltd - 532523 - Communication To The Shareholders W.R.T. TDS On Final Dividend
Biocon announced a final dividend of Re. 0.50 per equity share for FY2025-26, subject to shareholder approval at the upcoming AGM. The company has also shared communication regarding the deduction of Tax at Source (TDS) on this dividend.
Jun 22 2026 19:43:29
Biocon Ltd - 532523 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Biocon shareholders approved a preferential issue of equity shares for consideration other than cash, a key capital-raising move. Additionally, Mr. Shreehas Pradeep Tambe was appointed as the new CEO & MD.
Jun 08 2026 20:50:15
Biocon Ltd - 532523 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Biocon shareholders passed all 10 postal ballot resolutions. Key approvals include revised remuneration for the Chairperson, appointment of a new CEO & MD, and a preferential equity share issuance. All resolutions were approved with high voting majorities.
Jun 08 2026 20:43:31
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Biocon's management is scheduled to participate in Macquarie's Healthcare Tour - Plant Visit on June 11, 2026, in Bangalore. This meeting is with analysts and institutional investors. The company confirmed no UPSI will be disclosed.
Jun 08 2026 20:03:01
Biocon Ltd - 532523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Biocon issued a corrigendum to its postal ballot, updating terms for a preferential issue. The issue price is now ₹376.41 per share, and the swap ratio is 0.76159 equity shares for every 100 Biocon Biologics shares, aiming for full ownership of BBL.
May 29 2026 21:16:21
Read More